Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Rheumatology International
Published in: Rheumatology International 6/2003

01-11-2003 | Case Report

Dermatomyositis and malignancy of the pharynx in Caucasian patients: report of two observations

Authors: C. Botsios, P. Ostuni, P. Boscolo-Rizzo, M. C. Da Mosto, Leonardo Punzi, C. Marchiori

Published in: Rheumatology International | Issue 6/2003

Login to get access

Abstract

The association between dermatomyositis and malignancy of the pharynx is rare among whites but not uncommon among Far Eastern and north African populations. We report two cases of Caucasian Italian patients with dermatomyositis associated, respectively, with nasopharyngeal and tonsillar carcinomas. The relationship between dermatomyositis and malignancy is also discussed.
Literature
1.
2.
Zantos D, Zhang Y, Felson D (1994) The overall and temporal association of cancer with polymyositis and dermatomyositis. J Rheumatol 21:1855–1859PubMed
3.
Hill C, Zhang Y, Sigurgeirsson B, Pukkala E, Mellemkjaer L, Airio A, Evans SR, Felson DT (2001) Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study. Lancet 357:96–100CrossRefPubMed
4.
Peng JC, Sheem TS, Hsu MM (1995) Nasopharyngeal carcinoma with dermatomyositis: analysis of 12 cases. Arch Otolaryngol Head Neck Surg 121:1298–1301
5.
Sasaki CT, Jassin B (2001) Cancer of the pharynx and larynx. Am J Med 111 [Suppl 8A]:118–123
6.
Shi W, Pataki I, MacMillan C, Pintilie M, Payne D, O'Sullivan B, Cummings BJ, Warde P, Liu FF (2002) Molecular pathology parameters in human nasopharyngeal carcinoma. Cancer 94:1997–2006CrossRefPubMed
7.
Chien YC, Chen JY, Liu MY, Yang HI, Hsu MM, Chen CJ, Yang CS (2001) Serologic markers of Epstein-Barr virus infection and nasopharyngeal carcinoma in Taiwanese men. N Engl J Med 345:1877–1882
8.
Pathmanathan R, Prasad U, Sadler R, Flynn K, Raab-Traub N (1995) Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma. N Engl J Med 333:693–698
9.
Pachman LM, Litt DL, Rowley AH, Hayford JR, Caliendo J, Heller S, Ticho BS, Christensen M, Patterson B, Ytterberg SR (1995) Lack of detection of enteroviral RNA or bacterial DNA in magnetic resonance imaging-directed muscle biopsies from twenty children with active untreated juvenile dermatomyositis. Arthritis Rheum 38:1513–1518PubMed
10.
Kovacs SO, Kovacs SC (1998) Dermatomyositis. J Am Acad Dermatol 39:899–920
11.
Plotz PH, Dalakas M, Leff RL, Love LA, Miller FW, Cronin MF (1989) Current concepts in the idiopathic inflammatory myopathies: polymyositis, dermatomyositis, and related disorders. Ann Intern Med 111:143–157PubMed
12.
Mascaro JM Jr, Hausmann G, Herrero C, Gran JM, Cid MC, Palon J, Mascaro JM (1995) Membrane attack complex deposits in cutaneous lesions of dermatomyositis. Arch Dermatol 131:1386–1392CrossRefPubMed
13.
Teo P, Tai TH, Choy D (1989) Nasopharyngeal carcinoma with dermatomyositis. Int J Radiat Oncol Biol Phys 16:471–474
Metadata
Title
Dermatomyositis and malignancy of the pharynx in Caucasian patients: report of two observations
Authors
C. Botsios
P. Ostuni
P. Boscolo-Rizzo
M. C. Da Mosto
Leonardo Punzi
C. Marchiori
Publication date
01-11-2003
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 6/2003
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-003-0319-y

Other articles of this Issue 6/2003

Rheumatology International 6/2003 Go to the issue

Original Article

Using 99mTc HMPAO brain SPECT to evaluate the effects of anticoagulant therapy on regional cerebral blood flow in primary antiphospholipid antibody syndrome patients with brain involvement—a preliminary report

Case Report

Differential diagnosis of high serum creatine kinase levels in systemic lupus erythematosus

Original Article

Use of complementary and alternative medicine by arthritis patients in a university hospital clinic serving rheumatology patients in Korea

Original Article

CD13/aminopeptidase N in collagen vascular diseases

Letter to the Editor

Ankylosing spondylitis: a perturbing psychosocial concern?

Letter to the Editor

When you hear hooves, don't forget zebras along with the horses
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits